NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial
The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation
Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say
Trending Stories
- “Father of tamoxifen” V. Craig Jordan dies at 76
- NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements
- Discovery of EGFR mutations dramatically changed lung cancer treatment
20th anniversary of landmark findings